Heroin substitute treatment should not be time limited, says report commissioned by government

被引：1
|
作者：
Torjesen, Ingrid
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 349卷
关键词：
D O I：
10.1136/bmj.g6715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 6 条
  • [1] Supervised injectable heroin treatment is expensive but cost effective, report says
    Watson, Rory
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [2] Government should investigate trusts that charge NHS patients for treatment, says Labour
    O'Dowd, Adrian
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [3] Menopause: Government must tackle "postcode lottery" of treatment, says report
    Iacobucci, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379 : o2464
  • [4] Government should not take "big stick" to NHS after Mid Staffs report, says think tank
    O'Dowd, Adrian
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [5] NHS must monitor time from presentation to treatment for all child patients, report says
    Mooney, Helen
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [6] Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study
    Minson, Adrian
    Hamad, Nada
    Cheah, Chan Y.
    Tam, Constantine S.
    Blombery, Piers
    Westerman, David A.
    Lade, Stephen
    Ritchie, David
    Koldej, Rachel M.
    Anderson, Mary Ann
    Khot, Amit
    Seymour, John F.
    Robertson, Molly
    Caldwell, Imogen R.
    Ryland, Georgina L.
    Xie, Jing
    Morgan, Huw
    Dickinson, Michael
    BLOOD, 2022, 140
1